DEA Failed To Explain Rejection Of Psilocybin Waiver To Treat Cancer Patients, Federal ...

Retrieved on: 2024-02-12 22:52:36

Tags for this article:

Entheogens

Psilocybin

Controlled Substances Act

Drug Enforcement Administration

Psychedelic drug

Right-to-try law

Legal status of psilocybin mushrooms

Sunil Aggarwal

Click the tags to see associated articles and topics

DEA Failed To Explain Rejection Of Psilocybin Waiver To Treat Cancer Patients, Federal .... View article details on HISWAI: https://www.marijuanamoment.net/dea-failed-to-explain-rejection-of-psilocybin-waiver-to-treat-cancer-patients-federal-appeals-court-challenge-says/

Summary

The article details Dr. Sunil Aggarwal's legal battle against the DEA's decision to deny access to psilocybin for terminally ill patients, referencing the Controlled Substances Act, federal right-to-try law signed by Donald Trump, and psilocybin's potential medical use.

Article found on: www.marijuanamoment.net

View Original Article